Research Grants 12 show all


$290.3K
2007

$1M
2013

$1M
2014

$1M
2015

$1M
2016

Patents 325show all

  • 130
    A61K - Preparations for medical, dental, or toilet purposes
  • 102
    C12N - Microorganisms or enzymes
  • 71
    C07K - Peptides
  • 15
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 12
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 10
    A01K - Animal husbandry
  • 7
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Clinical Trials 7show all

4Phase 22N/A1Phase 1

SEC Filings show all


23
8-K

7
D

6
10-Q

2
10-K

1
S-1

Contact Information

Louisville, CO
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-06-10$7,500,000$7,500,000Debt, Option to Acquire, Security to be Acquired, Other
2014-03-12$391,730$391,730Debt, Option to Acquire, Security to be Acquired
2010-02-03$17,999,124$17,999,124Equity
2009-05-20$13,000,000$13,000,000Equity, Option to Acquire, Security to be Acquired
2009-03-17$5,000,000$2,564,710Debt, Option to Acquire, Security to be Acquired
2007-09-27Unknown Unknown Other (Paper Filing)

Key Executives

  • Timothy C Rodell
    Executive Officer, Director
  • Jeff Rona
    Executive Officer
  • David Apelian
    Executive Officer
  • John Frenz
    Executive Officer
  • Darren Carroll
    Director
  • Ralph Christoffersen
    Director
  • J. William Freytag
    Director
  • Ehud Geller
    Director
  • Augustine Lawlor
    Director
  • Paul Mieyal
    Director
  • Dan J Mitchell
    Director
  • C Jeffrey Dekker
    Executive Officer
  • Kirk A Christoffersen
    Executive Officer
  • J William Freytag
    Director
  • Ralph E Christoffersen
    Director
  • Augustine J Lawlor
    Director
  • Paul A Mieyal
    Director
  • Pennina Safer
    Director
  • S Edward Torres
    Director